Title : Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.

Pub. Date : 2018 Oct

PMID : 30106444






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor of the mevalonate pathway that inhibits YAP bioactivity through nuclear translocation and total YAP expression, increased the cytotoxicity of EGFR inhibitors (cetuximab and gefitinib) against CRC cells. Simvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens